Spillover effects of restrictive drug formularies on physician prescribing behavior: Evidence from medicaid

Journal of Economics and Management Strategy

Volumn 14, Issue 3, 2005, Pages 755-773

  Wang, Y Richard ^a,b   Pauly, Mark V ^b  

^a ASTRAZENECA   (United Kingdom)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 24144487013     PISSN: 10586407     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1530-9134.2005.00081.x     Document Type: Article

References (13)

1. Baker, L., 1997. "The Effect of HMOs on Fee-for-Service Health Care Expenditures: Evidence from Medicare," Journal of Health Economics, 16, 453-481.
2. Carroll, N.V., 2002. "How Effectively Do Managed Care Organizations Influence Prescribing and Dispending Decisions?" American Journal of Managed Care, 8, 1041-1054.
3. Coscelli, A., 2000. "The Importance of Doctors' and Patients' Preferences in the Prescription Decision," Journal of Industrial Economics, XLVIII, 349-369.
4. Glied, S. and J.G. Zivin, 2002. "How Do Doctors Behave When Some (But Not All) of Their Patients are in Managed Care?" Journal of Health Economics, 21, 337-353.
5. Grytten, J. and R. Sorensen, 2003. "Practice Variation and Physician-Specific Effects," Journal of Health Economics, 22, 403-418.
6. Hellerstein, J.K., 1998. "The Importance of the Physician in the Generic versus Trade-Name Prescription Decision," RAND Journal of Economics, 29, 108-136.
7. Huskamp, H.A., P.A. Deverka, A.M. Epstein, R.S. Epstein, K. A. McGuigan, and R.G. Frank, 2003. "The Effect of Incentive-Based Formularies on Prescription-Drug Utilization and Spending," New England Journal of Medicine, 349, 2224-2232.
8. Miner, P.J., P.O. Katz, Y. Chen, and M. Sostek, 2003. "Gastric Acid Control with Esomeprazole, Lansoprazole, Omeprazole, Pantoprazole, and Rabeprazole: A Five-Way Crossover Study," American Journal of Gastroenterology, 98, 2616-2620.
9. National Pharmaceutical Council, 2002. "Pharmaceutical Benefits Under State Medical Assistance Programs, 2001," Available at http://www.npcnow.org/resources.asp, accessed on October 28, 2004.
10. Rector, T.S., M.D. Finch, P.M. Danzon, M.V. Pauly, and B.S. Manda, 2003. "Effect of Tiered Prescription Copayments on the Use of Preferred Brand Medications," Medical Care, 41, 398-406.
11. Scott-Levin, 2001. Managed Care Formulary Drug Audit: Fall 2001, Newton, PA: Scott-Levin.
12. Tamblyn, R., P. McLeod, J. A. Hanley, N. Girard, and J. Hurley, 2003. "Physician and Practice Characteristics Associated with the Early Utilization of New Prescription Drugs," Medical Care, 41, 895-908.
13. Wang, Y.R., M.V. Pauly, and Y.A. Lin, 2003. "Impact of Maine's Medicaid Drug Formulary Change on Non-Medicaid Markets: Spillover Effects of a Restrictive Drug Formulary," American Journal of Managed Care, 9, 686-696.